Literature DB >> 33972024

Image-guided Adaptive Radiotherapy for Bladder Cancer.

V Kong1, V N Hansen2, S Hafeez3.   

Abstract

Technological advancement has facilitated patient-specific radiotherapy in bladder cancer. This has been made possible by developments in image-guided radiotherapy (IGRT). Particularly transformative has been the integration of volumetric imaging into the workflow. The ability to visualise the bladder target using cone beam computed tomography and magnetic resonance imaging initially assisted with determining the magnitude of inter- and intra-fraction target change. It has led to greater confidence in ascertaining true anatomy at each fraction. The increased certainty of dose delivered to the bladder has permitted the safe reduction of planning target volume margins. IGRT has therefore improved target coverage with a reduction in integral dose to the surrounding tissue. Use of IGRT to feed back into plan and dose delivery optimisation according to the anatomy of the day has enabled adaptive radiotherapy bladder solutions. Here we undertake a review of the stepwise developments underpinning IGRT and adaptive radiotherapy strategies for external beam bladder cancer radiotherapy. We present the evidence in accordance with the framework for systematic clinical evaluation of technical innovations in radiation oncology (R-IDEAL).
Copyright © 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaption; CBCT; MRI; adaptive radiotherapy; bladder cancer; image guidance

Year:  2021        PMID: 33972024     DOI: 10.1016/j.clon.2021.03.023

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac.

Authors:  A Mitchell; M Ingle; G Smith; J Chick; S Diamantopoulos; E Goodwin; T Herbert; R Huddart; H McNair; U Oelfke; S Nill; A Dunlop; S Hafeez
Journal:  Clin Transl Radiat Oncol       Date:  2022-04-26

2.  Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.

Authors:  David S Lakomy; Jinzhong Yang; Sastry Vedam; Jihong Wang; Belinda Lee; Angela Sobremonte; Pamela Castillo; Neil Hughes; Mustefa Mohammedsaid; Anuja Jhingran; Ann H Klopp; Seungtaek Choi; C David Fuller; Lilie L Lin
Journal:  Pract Radiat Oncol       Date:  2022-03-09

3.  Mapping Local Failure Following Bladder Radiotherapy According to Dose.

Authors:  H Abdel-Aty; K Warren-Oseni; S Bagherzadeh-Akbari; V N Hansen; K Jones; V Harris; M P Tan; D Mcquaid; H A McNair; R Huddart; A Dunlop; S Hafeez
Journal:  Clin Oncol (R Coll Radiol)       Date:  2022-06-09       Impact factor: 4.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.